These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β. Park H; Kam TI; Kim Y; Choi H; Gwon Y; Kim C; Koh JY; Jung YK Hum Mol Genet; 2012 Jun; 21(12):2725-37. PubMed ID: 22419736 [TBL] [Abstract][Full Text] [Related]
23. Dissociation of tau toxicity and phosphorylation: role of GSK-3beta, MARK and Cdk5 in a Drosophila model. Chatterjee S; Sang TK; Lawless GM; Jackson GR Hum Mol Genet; 2009 Jan; 18(1):164-77. PubMed ID: 18930955 [TBL] [Abstract][Full Text] [Related]
24. Aß40 displays amyloidogenic properties in the non-transgenic mouse brain but does not exacerbate Aß42 toxicity in Drosophila. De Mena L; Smith MA; Martin J; Dunton KL; Ceballos-Diaz C; Jansen-West KR; Cruz PE; Dillon KD; Rincon-Limas DE; Golde TE; Moore BD; Levites Y Alzheimers Res Ther; 2020 Oct; 12(1):132. PubMed ID: 33069251 [TBL] [Abstract][Full Text] [Related]
25. Protein kinase FA/glycogen synthase kinase-3 alpha after heparin potentiation phosphorylates tau on sites abnormally phosphorylated in Alzheimer's disease brain. Yang SD; Yu JS; Shiah SG; Huang JJ J Neurochem; 1994 Oct; 63(4):1416-25. PubMed ID: 7931292 [TBL] [Abstract][Full Text] [Related]
26. Microtubule-affinity regulating kinase family members distinctively affect tau phosphorylation and promote its toxicity in a Drosophila model. Sultanakhmetov G; Kato I; Asada A; Saito T; Ando K Genes Cells; 2024 Apr; 29(4):337-346. PubMed ID: 38329182 [TBL] [Abstract][Full Text] [Related]
27. SH2B1 is Involved in the Accumulation of Amyloid-β42 in Alzheimer's Disease. Shen Y; Xia Y; Meng S; Lim NK; Wang W; Huang F J Alzheimers Dis; 2017; 55(2):835-847. PubMed ID: 27802221 [TBL] [Abstract][Full Text] [Related]
28. PI3K activation prevents Aβ42-induced synapse loss and favors insoluble amyloid deposit formation. Arnés M; Romero N; Casas-Tintó S; Acebes Á; Ferrús A Mol Biol Cell; 2020 Feb; 31(4):244-260. PubMed ID: 31877058 [TBL] [Abstract][Full Text] [Related]
29. The distinctive role of tau and amyloid beta in mitochondrial dysfunction through alteration in Mfn2 and Drp1 mRNA Levels: A comparative study in Drosophila melanogaster. Abtahi SL; Masoudi R; Haddadi M Gene; 2020 Sep; 754():144854. PubMed ID: 32525045 [TBL] [Abstract][Full Text] [Related]
30. Active full-length DNA Aβ Rosenberg RN; Fu M; Lambracht-Washington D Alzheimers Res Ther; 2018 Nov; 10(1):115. PubMed ID: 30454039 [TBL] [Abstract][Full Text] [Related]
31. Glial Draper Rescues Aβ Toxicity in a Ray A; Speese SD; Logan MA J Neurosci; 2017 Dec; 37(49):11881-11893. PubMed ID: 29109235 [TBL] [Abstract][Full Text] [Related]
32. Differential dysregulation of CREB and synaptic genes in transgenic Drosophila melanogaster expressing shaggy (GSK3), Tau Ataellahi F; Masoudi R; Haddadi M Mol Biol Rep; 2023 Feb; 50(2):1101-1108. PubMed ID: 36399243 [TBL] [Abstract][Full Text] [Related]
33. MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer's disease granulovacuolar degeneration bodies. Lund H; Gustafsson E; Svensson A; Nilsson M; Berg M; Sunnemark D; von Euler G Acta Neuropathol Commun; 2014 Feb; 2():22. PubMed ID: 24533944 [TBL] [Abstract][Full Text] [Related]
34. S6K/p70S6K1 protects against tau-mediated neurodegeneration by decreasing the level of tau phosphorylated at Ser262 in a Drosophila model of tauopathy. Chiku T; Hayashishita M; Saito T; Oka M; Shinno K; Ohtake Y; Shimizu S; Asada A; Hisanaga SI; Iijima KM; Ando K Neurobiol Aging; 2018 Nov; 71():255-264. PubMed ID: 30172839 [TBL] [Abstract][Full Text] [Related]
35. Expressing miR-282 mitigates Aβ42-induced neurodegeneration in Alzheimer's model in Drosophila. Huang YH; Shih HW; Tsai YC Biochem Biophys Res Commun; 2024 Nov; 734():150768. PubMed ID: 39357339 [TBL] [Abstract][Full Text] [Related]
36. The chaperone domain BRICHOS prevents CNS toxicity of amyloid-β peptide in Drosophila melanogaster. Hermansson E; Schultz S; Crowther D; Linse S; Winblad B; Westermark G; Johansson J; Presto J Dis Model Mech; 2014 Jun; 7(6):659-65. PubMed ID: 24682783 [TBL] [Abstract][Full Text] [Related]
37. Transgenic Drosophila models of Alzheimer's disease and tauopathies. Iijima-Ando K; Iijima K Brain Struct Funct; 2010 Mar; 214(2-3):245-62. PubMed ID: 19967412 [TBL] [Abstract][Full Text] [Related]
38. Drosophila Eye Model to Study Neuroprotective Role of CREB Binding Protein (CBP) in Alzheimer's Disease. Cutler T; Sarkar A; Moran M; Steffensmeier A; Puli OR; Mancini G; Tare M; Gogia N; Singh A PLoS One; 2015; 10(9):e0137691. PubMed ID: 26367392 [TBL] [Abstract][Full Text] [Related]
39. gamma-cleavage-independent functions of presenilin, nicastrin, and Aph-1 regulate cell-junction organization and prevent tau toxicity in vivo. Doglio LE; Kanwar R; Jackson GR; Perez M; Avila J; Dingwall C; Dotti CG; Fortini ME; Feiguin F Neuron; 2006 May; 50(3):359-75. PubMed ID: 16675392 [TBL] [Abstract][Full Text] [Related]
40. Drosophila melanogaster as a model organism for Alzheimer's disease. Prüßing K; Voigt A; Schulz JB Mol Neurodegener; 2013 Nov; 8():35. PubMed ID: 24267573 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]